The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer’s Cholinergic Atrophy
The cause of the loss of basal forebrain cholinergic neurons (BFCNs) and their terminal synapses in the cerebral cortex and hippocampus in Alzheimer’s disease (AD) has provoked a decades-long controversy. The cholinergic phenotype of this neuronal system, involved in numerous cognitive mechanisms, i...
Main Authors: | Sonia Do Carmo, Benjamin Kannel, A. Claudio Cuello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/1/16 |
Similar Items
-
The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
by: A. Claudio Cuello, et al.
Published: (2019-02-01) -
Cellular birthdate predicts laminar and regional cholinergic projection topography in the forebrain
by: Kathryn C Allaway, et al.
Published: (2020-12-01) -
A functional topography within the cholinergic basal forebrain for encoding sensory cues and behavioral reinforcement outcomes
by: Blaise Robert, et al.
Published: (2021-11-01) -
Activation of cholinergic basal forebrain neurons improved cognitive functions in adult-onset hypothyroid mice
by: Yong-Xia Xu, et al.
Published: (2022-09-01) -
Enhanced TrkA signaling impairs basal forebrain-dependent behavior
by: Laura Calvo-Enrique, et al.
Published: (2023-09-01)